Top

Published in:

01-12-2010 | Integrative Oncology

Mechanisms of Action for Acupuncture in the Oncology Setting

Authors: Jennifer A. M. Stone, BA, LAc, Peter A. S. Johnstone, MD, FACR

Published in: Current Treatment Options in Oncology | Issue 3-4/2010

Opinion statement

A growing body of literature supports the use of acupuncture in the oncology clinic for the relief of symptoms caused by cancer treatments. Several clinical trials are currently supported by the National Institutes of Health to assess the efficacy of such treatments, as evidenced by the listings in the National Institutes of Health Computer Retrieval of Information on Scientific Projects (CRISP) database. However, little is known about the mechanisms of action behind the effects of acupuncture. A biomedical database search for articles in the English-language literature revealed studies examining the effect of acupuncture on fibroblast cells, a decrease of inflammatory cytokines, an increase of T-lymphocytes, and increasing adenosine, neuropeptides, opioid peptides, peptide hormones, and stem cells. This limited review attempts to reveal some possible mechanisms of action for the effects of acupuncture for symptom relief in the oncology setting.

World Health Organization, Acupuncture: Review and Analysis of Reports on Controlled Clinical Trials. http://apps.who.int/medicinedocs/en/d/Js4926e/5.html

Acupuncture. NIH Consens Statement 1997, 15(5):1–34. http://www.ncbi.nlm.nih.gov/pubmed/9809733

Johnstone PA, Polston GR, Niemtzow RC: Integration of acupuncture into the oncology clinic. Palliat Med 2002, 16(3):235–239.CrossRefPubMed

Wong R, Sagar S: Acupuncture treatment for chemotherapy-induced peripheral neuropathy—a case series. Acupunct Med 2006, 24(2):87–91.CrossRefPubMed

Shen J, Wenger N, Glaspy J: Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 2000, 284(21):2755–2761.CrossRefPubMed

Johnstone PA, Niemtzow RC, Riffenburgh RH: Acupuncture for xerostomia: clinical update. Cancer 2002, 94(4):1151–1156.CrossRefPubMed

Molassiotis A, Sylt P, Diggins H: The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med 2007, 15(4):228–237.CrossRefPubMed

8.•

Lu W, Matulonis UA, Doherty-Gilman A, et al.: Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial. J Altern Complement Med 2009, 15(7):745–753.CrossRefPubMed

Zhou Y, Garcia M, Chang D, et al.: Multiple myeloma, painful neuropathy, acupuncture? Am J Oncol 2009, 32(3):319–325.CrossRef

10.

Schroder S, Liepert J, Remppis A, et al.: Acupuncture treatment improves nerve conduction in peripheral neuropathy. Eur J Neurol 2007, 14(3):276–281.PubMed

11.

Cabyoglu M, Ergene N, Tan U: The mechanism of acupuncture and clinical applications. Int J Neurosci 2006, 116(2):115–125.CrossRefPubMed

12.•

Pfister DG, Cassileth BR, Deng GE, et al.: Acupuncture for pain and dysfunction after head and neck dissection: results of a randomised controlled trial. J Clin Oncol 2010, 28(15):2565–2570.CrossRefPubMed

13.•

Crew KD, Capodice JL, Greenlee H: Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol 2010, 28(7):1154–1160. Epub 2010 Jan 25.CrossRefPubMed

14.

Campbell N, Reese J: In Biology, 7th edn. Edited by Wilber B. San Francisco: Pearson Educational Inc.; 2005:901–902

15.

Langevin HM, Yandow JA: Relationship of acupuncture points and meridians to connective tissue planes. Anat Rec 2002, 269:257–265.CrossRefPubMed

16.

Langevin HM, Bouffard NA, Badger GJ, et al.: Subcutaneous tissue fibroblast cytoskeletal remodeling induced by acupuncture: evidence for a mechanotransduction-based mechanism. J Cell Physiol 2006, 207(3):767–774.CrossRefPubMed

17.

US National Library of Medicine, Unified Medical Language System. http://ghr.nlm.nih.gov/glossary=fibroblast

18.

Chae Y, Hong MS, Kim GH, et al.: Protein array analysis of cytokine levels on the action of acupuncture in carrageenan-induced inflammation. Neurol Res 2007, 29(Suppl 1):S55–S58.CrossRefPubMed

19.•

Goldman N, Chen M, Fujita T, et al.: Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci 2010, 13(7):883–888.CrossRefPubMed

20.

Melzack R, Wall P: Pain mechanisms: a new theory. Science 1965, 150(699):971–979.CrossRefPubMed

21.

Wang SM, Kain ZN, White P: Acupuncture analgesia. I. The scientific basis. Anesth Analg 2008, 106(2):602–610.CrossRefPubMed

22.

Casey KL: Forebrain mechanisms of nociception and pain: analysis through imaging. Proc Natl Acad Sci USA 1999, 96:7668–7674.CrossRefPubMed

23.

Liu XY, Zhou HF, Pan YL: Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats. Exp Neurol 2004, 189(1):189–196.CrossRefPubMed

24.

Shen EY, Lai YJ: The efficacy of frequency-specific acupuncture stimulation on extracellular dopamine concentration in striatum—a rat model study. Neurosci Lett 2007, 415(2):179–184.CrossRefPubMed

25.

Yang J, Lin BC: Hypothalamic paraventricular nucleus plays a role in acupuncture analgesia through the central nervous system in the rat. Acupunct Electrother Res 1992, 17:209–220.PubMed

26.

Yang J, Liu WY, Song CY, et al.: Through central arginine vasopressin, not oxytocin and endogenous opiate peptides, glutamate sodium induces hypothalamic paraventricular nucleus enhancing acupuncture analgesia in the rat. Neurosci Res 2006, 54(1):49–56.CrossRefPubMed

27.

Wu GC, Zhu J, Cao X: Involvement of opioid peptides of the preoptic area during electroacupuncture analgesia. Acupunct Electrother Res 1995, 20(1):1–6.PubMed

28.

Okumura M, Toriizuka K, Iijima K, et al.: Effects of acupuncture on peripheral T lymphocyte subpopulation and amounts of cerebral catecholamines in mice. Acupunct Electrother Res 1999, 24(2):127–139.PubMed

29.

Mori H, Nishijo K, Kawamura H, et al.: Unique immunomodulation by electro-acupuncture in humans possibly via stimulation of the autonomic nervous system. Neurosci Lett 2002, 320(1–2):21–24.CrossRefPubMed

30.

Jong MS, Hwang SJ, Chen FP: Effects of electro-acupuncture on serum cytokine level and peripheral blood lymphocyte subpopulation at immune-related and non-immune-related points. Acupunct Electrother Res 2006, 31(1–2):45–59.PubMed

31.

Arranz L, Guayerbas N, Siboni L, et al.: Effect of acupuncture treatment on the immune function impairment found in anxious women. Am J Chin Med 2007, 35(1):35–51.CrossRefPubMed

32.•

Zeng F, Song WZ, Liu XG, et al.: Brain areas involved in acupuncture treatment on functional dyspepsia patients: a PET-CT study. Neurosci Lett 2009, 456(1):6–10.CrossRefPubMed

33.

Nishijo K, Mori H, Yosikawa K: Decreased heart rate by acupuncture stimulation in humans via facilitation of cardiac vagal activity and suppression of cardiac sympathetic nerve. Neurosci Lett 1997, 227:165–168.CrossRefPubMed

34.

Tada H, Fujita M, Harris M, et al.: Neural mechanism of acupuncture-induced gastric relaxations in rats. Dig Dis Sci 2003, 48(1):59–68.CrossRefPubMed

35.

Sajdyk TJ, Fitz SD, Shekhar A: The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress 2006, 9(1):21–28.CrossRefPubMed

36.

Park HJ, Chae Y, Jang J, et al.: The effect of acupuncture on anxiety and neuropeptide Y expression in the basolateral amygdala of maternally separated rats. Neurosci Lett 2005, 377(3):179–184.CrossRefPubMed

37.

Chae Y, Yeom M, Han JH, et al.: Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms. Neurosci Lett 2008, 430(2):98–102.CrossRefPubMed

38.•

Moldenhauer S, Burgauner M, Hellweg R, et al.: Mobilization of CD133(+)CD34(−) cells in healthy individuals following whole-body acupuncture for spinal cord injuries. J Neurosci Res 2010, 88(8):1645–1650.PubMed

Title: Mechanisms of Action for Acupuncture in the Oncology Setting
Authors: Jennifer A. M. Stone, BA, LAc
Peter A. S. Johnstone, MD, FACR
Publication date: 01-12-2010
Publisher: Springer US
Published in: Current Treatment Options in Oncology / Issue 3-4/2010
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI: https://doi.org/10.1007/s11864-010-0128-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Opinion statement

Please log in to get access to this content

Other articles of this Issue 3-4/2010

Mind–Body Therapies in Integrative Oncology

Phytochemicals in the Oncology Setting

Duration of Chemotherapy for Early Stage Breast Cancer: Have We Reached the Limit? What is the Survival Impact of Amenorrhea?

Breast Cancer Prevention: An Update of the STAR Trial

Erratum to: Exercise Therapy in the Management of Solid Tumors

Acupuncture in the Oncology Setting: Clinical Trial Update

Keynote webinar | Spotlight on antibody–drug conjugates in cancer